Evidence map›Paper›PMID 42850248›Full record

ArticleNature communications2026

Contact percolation governs collective motility via mechano-chemical feedback in heterogeneous breast cancer.

Leonardo Barzaghi, Camillo Mazzella, Chiara Guidolin, Joseph Ackermann, Edoardo Bellini, Andrew E Massey, Stefano Villa, Emanuela Frittoli, Brenda J Green, Andrea Palamidessi and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Leonardo Barzaghi *IFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy. leonardo.barzaghi@ifom.eu.ORCID http://orcid.org/0000-0002-3174-6441
Camillo Mazzella *IFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy.ORCID http://orcid.org/0009-0005-4436-6762
Chiara Guidolin *Department of Medical Biotechnology and Translational Medicine, University of Milan, Segrate, Italy.
Joseph AckermannLaboratoire Jean Perrin, CNRS/Sorbonne Université, Paris, France.
Edoardo BelliniIFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy.ORCID http://orcid.org/0000-0001-9766-7685
Andrew E MasseySection on Mechanobiology, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0001-7688-5501
Stefano VillaDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Segrate, Italy.ORCID http://orcid.org/0000-0002-9159-0952
Emanuela FrittoliIFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy.
Brenda J GreenIFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy.ORCID http://orcid.org/0000-0002-4274-0969
Andrea PalamidessiIFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy.ORCID http://orcid.org/0000-0002-7134-7023
Angela CattaneoCogentech SRL Benefit Corporation, Milan, Italy.
Angela BachiIFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy.ORCID http://orcid.org/0000-0003-4842-6556
Valeria CancilaDepartment of Health Sciences, Human Pathology Section, University of Palermo School of Medicine, Palermo, Italy.
Claudio TripodoIFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy.
Simona PoloIFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy.ORCID http://orcid.org/0000-0001-5536-9399
Roberto CerbinoFaculty of Physics, University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0003-0434-7741
Alexander X Cartagena-RiveraSection on Mechanobiology, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0001-6227-2499
Raphaël VoituriezLaboratoire Jean Perrin, CNRS/Sorbonne Université, Paris, France.ORCID http://orcid.org/0000-0001-8746-5713
Fabio GiavazziDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Segrate, Italy. fabio.giavazzi@unimi.it.ORCID http://orcid.org/0000-0003-4930-0592
Giorgio ScitaIFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy. giorgio.scita@ifom.eu.ORCID http://orcid.org/0000-0001-7984-1889

Funding

Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) 22759Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) 22821EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 801 101071470
6 · The paper itself

Abstract

Breast carcinomas are heterogeneous tissues containing cell populations with distinct molecular programs and mechanical states. How this heterogeneity drives collective invasion remains unclear. Tissue fluidization, the shift from a crowded, solid-like state to a more deformable and mobile one, promotes collective motion of cancer cells. Using percolation theory, which explains how connected clusters generate system-wide behavior, here we show that a critical fraction of motile cells expressing RAB5A, a membrane-trafficking regulator, triggers an abrupt transition to coordinated, flock-like movement in heterogeneous breast cancer monolayers. Above this threshold, RAB5A cells form connected networks that mechanically and chemically reprogram neighboring control cells. Under these conditions, control cells acquire aligned migratory protrusions, soften and elongate through E-cadherin-dependent EGFR-MAPK signaling. They further activate a STAT1/STAT2-dependent inflammatory gene program through both cell contact and soluble signals. Our findings reveal a mechano-chemical switch through which local tumor heterogeneity organizes tissue-wide fluidization, inflammation and invasive behavior in breast cancer.

Indexed as

Breast NeoplasmsCell MovementAnimalsCadherinsCell Line, TumorErbB ReceptorsFeedback, PhysiologicalFemaleGene Expression Regulation, NeoplasticHumansNeoplasm Invasivenessrab5 GTP-Binding ProteinsCadherinsErbB Receptorsrab5 GTP-Binding Proteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.